Divalproex sodium and Moxetumomab Pasudotox-tdfk
Determining the interaction of Divalproex sodium and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: divalproex sodium
Brand name: Depakote ER, Depakote Sprinkles, Depakote, Depakene, Depacon
Synonyms: Divalproex
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Divalproex sodium-Moxetumomab pasudotox-tdfk Intravenous
- Divalproex sodium-Moxifloxacin
- Divalproex sodium-Moxifloxacin (Systemic)
- Divalproex sodium-Moxifloxacin Hydrochloride
- Divalproex sodium-Moxifloxacin Injection
- Divalproex sodium-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Divalproex Sprinkle
- Moxetumomab Pasudotox-tdfk-Divalproex Sprinkle Capsules
- Moxetumomab Pasudotox-tdfk-Divigel
- Moxetumomab Pasudotox-tdfk-Divigel 0.75 mg/packet for use on skin
- Moxetumomab Pasudotox-tdfk-Divigel Transdermal
- Moxetumomab Pasudotox-tdfk-Divista